CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Epidural Injections for Pain Management

Defines medical necessity criteria, prior authorization guidance, coding, and limitations for epidural steroid injections (cervical, thoracic, lumbar/caudal, transforaminal) for Commercial Products of BCBSRI. Excludes Medicare Advantage guidance and notes benefits may vary by contract.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyEpidural Injections for Pain Management

Policy CodePolicy N/A

Change TypeNo material change

Effective Date03/01/2024

Next Review Date

Key ActionPrior authorization is recommended and obtained via the online tool; an approved authorization is valid for up to 4 epidural injections in one 12-month period — request additional authorization if exceeding this limit.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes were made in this update.

6Medically necessary CPT codes listed

4Max injections with one authorization (12 months)

90 daysMinimum interval between injections (recommended)

2VAS pain strata

Coverage Summary

Epidural injections (ESIs) are used for neck or back pain that has not responded to conservative measures; they deliver steroid or other therapeutic substances into the epidural space to reduce inflammation and relieve pressure on neural structures. This policy defines medical necessity criteria, prior authorization guidance, coding, and limits for ESIs (cervical, thoracic, lumbar/caudal, and transforaminal) for Commercial Products of BCBSRI. Medicare Advantage guidance is excluded and benefits may vary by group/contract.

Effective date: 03/01/2024. Policy last reviewed: 06/05/2024.

Key thresholds and therapy durations

VAS criteria>=7/10 (with unilateral nerve-root signs, position-unrelieved pain, ADL interference, and imaging-confirmed nerve root compression) OR 3-6/10 (with unilateral nerve-root distribution and imaging-confirmed nerve root compression plus specified conservative therapy requirements)

Conservative therapy durations for non-specific low back painNSAIDs/acetaminophen >= 3 weeks; Activity modification >= 6 weeks; Physical therapy >= 6 weeks

Conservative therapy durations for radiculopathy (option 1)NSAIDs/acetaminophen >= 1 week; Activity modification >= 1 week; Physical therapy >= 1 week

Conservative therapy durations for radiculopathy (option 2)NSAIDs/acetaminophen >= 3 weeks; Activity modification >= 6 weeks; Physical therapy >= 6 weeks

Interval between injectionsMinimum ~90 days between injections

Maximum injections per 12 monthsNo more than 4 injections in a 12-month period per authorization (additional authorization required to exceed)

Coding

Medically Necessary CPT codes (when criteria met)CPTCovered

62320	Interlaminar epidural or subarachnoid, cervical or thoracic; without imaging guidance
62321	Interlaminar epidural or subarachnoid, cervical or thoracic; with imaging guidance (ie, fluoroscopy or CT)
62322	Interlaminar epidural or subarachnoid, lumbar or sacral (caudal); without imaging guidance
62323	Interlaminar epidural or subarachnoid, lumbar or sacral (caudal); with imaging guidance (ie, fluoroscopy or CT)
64479	Transforaminal epidural, with imaging guidance (fluoroscopy or CT); cervical or thoracic, single level
64483	Transforaminal epidural, with imaging guidance (fluoroscopy or CT); lumbar or sacral, single level

Provider Actions

Prior Authorization

Prior authorization recommended for Commercial Products

Prior authorization is recommended for Commercial Products and must be obtained via the online tool for participating providers. The listed CPT codes are affected. An approved authorization is valid for up to 4 epidural injections in a 12-month period from the requested date of service.

62320
62321
62322
62323
64479
64483
Approved authorization valid for 4 injections in one 12-month period

Billing Rule

Authorization validity and limits

An approved authorization request is valid for up to 4 epidural injections in a 12-month period. If the member will exceed the initially approved number of injections, an additional authorization request is required. The policy recommends a period of no less than 90 days between injections.

Minimum interval between injections: 90 days

Documentation Required

Documentation of conservative therapy and imaging

Providers must document durations of conservative treatments when required by the criteria and must document imaging or testing evidence of nerve root compression when the radiculopathy criteria require it.

NSAIDs or acetaminophen (durations per criteria: ≥ 3 weeks for non-specific LBP; ≥ 1 week or ≥ 3 weeks options for radiculopathy)
Activity modification (durations per criteria: ≥ 6 weeks for non-specific LBP; ≥ 1 week or ≥ 6 weeks options for radiculopathy)
Physical therapy (durations per criteria: ≥ 6 weeks for non-specific LBP; ≥ 1 week or ≥ 6 weeks options for radiculopathy)
Imaging or testing evidence of nerve root compression when required by radiculopathy criteria

Denial Risk

Exclusion conditions may render treatment not medically necessary

Claims may be denied if exclusionary conditions listed in the policy are present or if the medical criteria (including required conservative therapy durations and VAS thresholds) are not met.

Local infection at injection site
Increased intracranial pressure
Epidural metastases

Background, Evidence & Definitions

Epidural steroid injections are intended for patients with neck or back pain refractory to conservative therapies; they may improve pain by reducing inflammation and relieving pressure on nerve roots or other pain-generating structures.

The evidence base for radiculopathy includes randomized trials and meta-analyses that show reduced pain in the short- to intermediate-term (up to 6 months), but no consistent long-term benefit. For nonspecific low back pain, most trials are low quality and the evidence is insufficient to demonstrate a net health benefit.

Techniques and study outcomes are heterogeneous (different approaches such as translaminar, transforaminal, caudal; with or without fluoroscopic guidance), which contributes to variability in results.

Serious adverse events are rare but have been reported; trials generally report mild adverse events but rates of serious events are not well defined.

Evidence summary	Key point
Short- to intermediate-term benefit for radiculopathy
Meta-analyses and RCTs show reduced pain up to 6 months; no long-term benefit demonstrated
Evidence for nonspecific low back pain
Most trials low quality with insufficient evidence of net health benefit

Term	Definition
Epidural injections (ESIs)
Injection of steroid or other therapeutic substances into the epidural space via translaminar, transforaminal, or caudal approaches, with or without fluoroscopic guidance.
Radiculopathy
Irritation of one or more spinal nerve roots causing radiating pain, numbness, or weakness in a dermatomal distribution.